Cargando…
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158940/ https://www.ncbi.nlm.nih.gov/pubmed/32278362 http://dx.doi.org/10.1016/S0140-6736(20)30858-8 |
| _version_ | 1783522580035010560 |
|---|---|
| author | Feldmann, Marc Maini, Ravinder N Woody, James N Holgate, Stephen T Winter, Gregory Rowland, Matthew Richards, Duncan Hussell, Tracy |
| author_facet | Feldmann, Marc Maini, Ravinder N Woody, James N Holgate, Stephen T Winter, Gregory Rowland, Matthew Richards, Duncan Hussell, Tracy |
| author_sort | Feldmann, Marc |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7158940 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71589402020-04-15 Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed Feldmann, Marc Maini, Ravinder N Woody, James N Holgate, Stephen T Winter, Gregory Rowland, Matthew Richards, Duncan Hussell, Tracy Lancet Comment Elsevier Ltd. 2020 2020-04-09 /pmc/articles/PMC7158940/ /pubmed/32278362 http://dx.doi.org/10.1016/S0140-6736(20)30858-8 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Feldmann, Marc Maini, Ravinder N Woody, James N Holgate, Stephen T Winter, Gregory Rowland, Matthew Richards, Duncan Hussell, Tracy Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title | Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title_full | Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title_fullStr | Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title_full_unstemmed | Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title_short | Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed |
| title_sort | trials of anti-tumour necrosis factor therapy for covid-19 are urgently needed |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158940/ https://www.ncbi.nlm.nih.gov/pubmed/32278362 http://dx.doi.org/10.1016/S0140-6736(20)30858-8 |
| work_keys_str_mv | AT feldmannmarc trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT mainiravindern trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT woodyjamesn trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT holgatestephent trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT wintergregory trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT rowlandmatthew trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT richardsduncan trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded AT husselltracy trialsofantitumournecrosisfactortherapyforcovid19areurgentlyneeded |